Our wholly-owned R&D facility is located in the beautiful and historical city of Nanjing, capital of Jiangsu province, the People's Republic of China. Nanjing is home to many top rank universities, such as Nanjing University and National Pharmaceutical University. Our R&D unit is led by US PhD returnees with more than 10+ years of US pharmaceutical R&D experience. We have 50+ R&D chemists and equipped with top-notch analytical instruments such as NMR, HPLC-MS, and GC-MS, which allow us to provide fast and quality services to our clients. Our R&D is equipped to perform mg-scale to tens of kg-scale synthesis and with a temperature range of –80 ºC to 300 º C and with reactor size up to 100L reactors. Furthermore, we have purchased a 25,000 m2 land for immediate expansion to build a 12,000 m2 (~130,000 ft2) R&D facility.
Manufacturing
Our wholly-owned 108,000 m2 (~ 25 acres) ICH cGMP pilot and manufacturing facility is located in the beautiful seaport city of Lianyungang, Jiangsu province, the People's Republic of China. Lianyungang is the pharmaceutical manufacturing center of Jiangsu province and of that of China. Lianyungang has one of the largest seaports in China and this allows us to ship products to our clients in a timely and cost effective manner. Our manufacturing facility is strictly managed under ICH cGMP, regardless of products, to ensure we provide quality products to clients using equipments of known history and cleaning records. Our pilot and production manufacturing facility is equipped with reactors ranged from 50 L to 5,000L, both SS and GSL, and with a temperature range from –80 ºC to 250 ºC. In addition, we have hydrogenation reactors up to 2000L size, and dedicated high potency suites for highly potent and cytotoxic APIs.
